The effect of sodium-glucose cotransporter 2 inhibitors on myocardial electrophysiological processes in patients with chronic heart failure
https://doi.org/10.24884/1609-2201-2025-104-2-85-87
About the Authors
L. A. Khalilova
Pavlov University
Russian Federation
Russian Federation
Leyla A. Khalilova, Senior Assistant of the Department of Propaedeutics of Internal Diseases with clinic named after acad. M. D. Tushinksy
6–8, L’va Tolstogo str., Saint Petersburg, 197022
A. A. Churko
Pavlov University
Russian Federation
Russian Federation
Anna A. Churko, Assistant of the Department of Propaedeutics of Internal Diseases with clinic named after acad. M. D. Tushinksy
Saint Petersburg
I. Yu. Panina
Pavlov University
Russian Federation
Russian Federation
Irina Yu. Panina, Dr. of Sci. (Med.), Professor, Professor of the Department of Propaedeutics of Internal Diseases with clinic named after acad. M. D. Tushinksy
Saint Petersburg
A. N. Kulikov
Pavlov University
Russian Federation
Russian Federation
Alexander N. Kulikov, Dr. of Sci. (Med.), Professor, Head of the Department of Propaedeutics of Internal Diseases with clinic named after acad. M. D. Tushinksy, Head of the Department of Functional Diagnostics, Director of the Scientific and Clinical Research Center
Saint Petersburg
References
1. Karpushev A. V., Krasnova M. V., Ivkin D. Yu. et al. Possible mechanism of effect of the empagliflozin on cardiovascular mortality. Drug development & registration. 2024;13(4):223–230. (In Russ.). https://doi.org/10.33380/2305-2066-2024-13-4-1868.
2. Wu V. C., Chiu K. P., Wang C. L. et al. Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: a multi-center retrospective study. Front Cardiovasc Med. 2022;9:934193. https://doi.org/10.3389/fcvm.2022.934193.
3. Fernandes G. C., Fernandes A., Cardoso R. et al. Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials. Hearth Rhythm. 2021;18(7):1098–1105. https://doi.org/10.1016/j.hrthm.2021.03.028.
Review
For citations:
Khalilova L.A., Churko A.A., Panina I.Yu., Kulikov A.N. The effect of sodium-glucose cotransporter 2 inhibitors on myocardial electrophysiological processes in patients with chronic heart failure. New St. Petersburg Medical Records. 2025;(2):85-87. (In Russ.) https://doi.org/10.24884/1609-2201-2025-104-2-85-87
Views:
49
Email this article 